Microchip electrophoresis, with respect to "profiling of aβ peptides in the cerebrospinal fluid of patients with alzheimer's disease"

6Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aggregation of beta amyloid peptides especially Aβ1-42 in amyloid plaques is one of the major Â? neuropathological events in Alzheimer's disease. This event is normally accompanied by a relative reduction of the concentration of Aβ1-42 in the cerebrospinal fluid (CSF) of patients developing the signs of Alzheimer's disease. Here, we describe a microchip gel electrophoresis method in a polydimethylsiloxane (PDMS) chip that enables rapid profiling of major Aβ peptides. The method was applied to compare the relative concentration of Aβ1-42 with other Aβ peptides, for example, Aβ 1-40 in CSF. In order to increase the sensitivity of detection, Aβ peptides in the CSF samples were first captured and concentrated using magnetic beads coated with specific anti-Aβ antibodies. © 2012 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Mohamadi, M. R., Verpillot, R., Taverna, M., Otto, M., & Viovy, J. L. (2012). Microchip electrophoresis, with respect to “profiling of aβ peptides in the cerebrospinal fluid of patients with alzheimer’s disease.” Methods in Molecular Biology, 869, 173–184. https://doi.org/10.1007/978-1-61779-821-4_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free